Cure My Disease

Don't miss your cure!

 Log in / Sign up

A targeted exercise and therapy plan may help new mothers beat back pain

NCT ID NCT07790848

Symptom relief Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests whether a structured physiotherapy program can reduce low back pain and improve function in women who gave birth within the last six months. The program combines core exercises, pelvic floor training, manual therapy, posture correction, and ergonomic advice over six weeks. Researchers will compare it with routine postpartum care in 40 women, measuring pain, disability, core endurance, fatigue, and quality of life. The goal is to see if this approach can become a standard part of maternal healthcare in Pakistan.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multimodal physiotherapy program including core stabilization exercises, pelvic floor training, manual therapy, posture correction, ergonomic education, and home exercise guidance
What this could lead to
If it works, this could support adding physiotherapy to routine postpartum care in Pakistan, helping new mothers recover from low back pain and regain daily function.
What could go wrong
This is a small early trial with 40 participants, so results may not apply broadly. The program requires six weeks of supervised sessions, and some women may not complete it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Within six months postpartum following vaginal or caesarean delivery. * Experiencing low back pain or lumbopelvic pain after childbirth. * Pain intensity ≥3 on the Numeric Pain Rating Scale during activity or rest. * Able to attend supervised physiotherapy sessions for six consecutive weeks. * Willing to provide informed consent and participate in follow-up assessments. Exclusion Criteria: * History of spinal surgery or diagnosed structural spinal deformities such as scoliosis, spondylolisthesis, or disc herniation. * Severe postpartum complications including postpartum haemorrhage, infection, or wound dehiscence limiting physical activity. * Pelvic organ prolapse grade II or above or severe pelvic floor dysfunction requiring specialized care. * Uncontrolled systemic illness such as diabetes mellitus, hypertension, or thyroid dysfunction affecting exercise tolerance. * Current participation in another structured physiotherapy or rehabilitation program for low back pain. * Neurological disorders or musculoskeletal conditions unrelated to postpartum low back pain that may affect outcomes.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back biomechanical dysfunctions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back biomechanical dysfunctions Post partum

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.